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ABSTRACT
Trithorax and polycomb group proteins are gener-
ally thought to antagonize one another. The tritho-
rax family member MLL (myeloid/lymphoid or mixed-
lineage leukemia) is presumed to activate Hox ex-
pression, counteracting polycomb-mediated repres-
sion. PC4 and SF2 interacting protein 1 (PSIP1)/p75,
also known as LEDGF, whose PWWP domain binds
to H3K36me3, interacts with MLL and tethers MLL fu-
sion proteins to HOXA9 in leukaemias. Here we show,
unexpectedly, that Psip1/p75 regulates homeotic
genes by recruiting not only MLL complexes, but
also the polycomb group protein Bmi1. In Psip1−/−
cells binding of Mll1/2, Bmi1 and the co-repressor
Ctbp1 at Hox loci are all abrogated and Hoxa and
Hoxd mRNA expression increased. Our data not only
reveal a potential mechanism of action for Psip1 in
the regulation of Hox genes but also suggest an un-
expected interplay between proteins usually consid-
ered as transcriptional activators and repressors.
INTRODUCTION
TheHomeotic (Hox) gene family encodes transcription fac-
tors essential for patterning the anterior–posterior body
axis. The developmental pattern of Hox gene expression is
thought to be maintained by two groups of proteins: Poly-
comb repressive complexes (PRCs) maintainHox genes in a
silent state (1). The PRC2 complex contains the Ezh2/Ezh1
histone methyltransferases (HMTs) that mediate H3K27
trimethylation (H3K27me3) (2) and PRC1 contains the
Bmi1 or Mel18/Ring1a/b heterodimer which can ubiqui-
tinate H2AK119 and can compact chromatin (3). Tritho-
rax (Trx) proteins (MLL proteins in mammals) of the
COMPASS-like family have histone H3 lysine 4 (H3K4)
methyl transferase activity and are generally thought to
maintain the active expression level ofHox genes (4,5), and
may function as anti-repressors to prevent the repressive
function of polycomb (6–8).
Six mammalian COMPASS-like complexes have been
identified, each with a SET domain-containing HMT sub-
unit including; Set1A/KMT2F, Set1B/KMT2G and four
MLL-family proteins––MLL1/KMT2A, Mll2/KMT2B,
MLL3/KMT2C, MLL4/KMT2D (9,10). Each of these
complexes associates with proteins that can modulate tar-
get site selection and enzymatic activity. Set1A/Bare associ-
ated withWdr82 (11,12), Mll1 andMll2 are associated with
Menin (5), Mll3 and Mll4 with PTIP (13).
Among the MLL genes, MLL1 has been the most ex-
tensively studied as it is frequently involved in leukemia-
associated chromosomal translocations, where its fusion to
a variety of proteins is accompanied by dysregulated Hox
expression in haematopoiesis (14). Mice mutant for Mll1,
or for its Set domain, have homeotic transformations of the
axial skeleton and aberrantHox gene expression (15,16). In
contrast to SET1A/B,Mll1 andMll2 have few target genes,
but these includeHox genes (17,18). However, the relation-
ship between Mlls and H3K4 methylation is complex. Mll1
is dispensable for most of the H4K4me3 atHox genes in fi-
broblasts (5) and in mouse embryonic stem cells (mESCs)
(18). But H3K4me3 at some Hox promoters in mESCs re-
quires Mll1, at others it requires Mll2, and at some it re-
quires both. Many promoters do not require either Mll1 or
Mll2 indicating that a third enzyme is responsible for H3K4
trimethylation on Hox genes (18). Indeed, recent in vitro
evidence indicates that Trx, Mll1 and Mll2 catalyse H3K4
monomethylation rather than H3K4me3 (19).
In flies Trx complexes bind to specific response DNA ele-
ments (TREs). Mammalian TREs have not been identified
and themechanism ofMLL recruitment toHox genes is not
clear. Two lncRNAs expressed from the Hoxa cluster, and
linked toHox gene activation, have been suggested to func-
tion through recruitment of the MLL1 complex. Mistral,
located betweenHoxa6 andHoxa7, has been reported to re-
*To whom correspondence should be addressed. Tel: +44 131 332 2471; Fax: +44 131 467 8456; Email: Wendy.Bickmore@igmm.ed.ac.uk.
Correspondence may also be addressed to Madapura M. Pradeepa. Tel: +44 131 332 2471; Fax: +44 131 467 8456; Email: pradeepa.mm@igmm.ed.ac.uk
Present address:
Heidi Sutherland, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia.
C© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 at A
lbert Slom
an Library, U
niversity of Essex on O
ctober 16, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
9022 Nucleic Acids Research, 2014, Vol. 42, No. 14
cruit WDR5 and theMLL1 complex to activateHoxa6 and
Hoxa7 transcription (20).HOTTIP is transcribed in an an-
tisense direction from the 5′ end ofHoxa13, and is reported
to be important for targetingWdr5 andMLL acrossHOXA
and for maintaining 5′ Hoxa expression and H3K4me3 in
distal tissues (21).
The menin tumor suppressor protein is a common com-
ponent ofMLL1 and 2 complexes, and has been reported to
be important for MLL recruitment to target genes and for
the regulation of Hox expression (22). Menin functions as
an adaptor molecule, binding to MLL1while also interact-
ing with the protein Psip1/p75 at a distinct surface. Neither
menin nor MLL1 alone can interact with Psip1 (23–25).
PC4 and SF2 interacting protein 1 (Psip1), previously
known as LEDGF, is a chromatin protein implicated in;
transcriptional regulation––including of Hox genes (26),
mRNA splicing (27,28), DNA repair (29) and HIV in-
tegration (30,31). Psip1 encodes two isoforms (p52 and
p75) which share a common N-terminal PWWP domain
that binds to H3K36me3 (28) and is required for MLL1-
mediated leukemic transformation (32) (Figure 1A). Psip1
p52, but not p75, interacts with splicing factors and can
modulate alternative splicing of weak exons (28). It is the
C-terminal domain of p75, absent in p52, which interacts
with MLL1 (32) and a variety of other proteins (33–35)
(Figure 1A). The mechanism by which Psip1/p75 regulates
transcription is not known.
Here, we show that Psip1/p75, rather than p52, is im-
portant in regulating Hoxa and Hoxd gene expression.
Psip1/p75 interacts with Mll1, and in Psip1−/− mouse
embryonic fibroblasts (MEFs) Mll1 and Mll2, but not
H3K4me3, levels are reduced on expressedHoxa andHoxd
genes. Unexpectedly, however, given the assumed associ-
ation of Mll1 with Hox activation, Hox genes are up-
regulated in the absence of Psip1 and the accompanying loss
of Mll1, suggesting that p75, while recruiting Mll1––a sup-
posed activator, acts to repress gene expression. Further-
more, we show that Psip1/p75 is also required to recruit the
polycomb group protein Bmi1, and the co-repressor Ctbp1
to expressed Hox genes.
This study reveals a potential mechanism through which
the p75 isoform of Psip1 regulates the expression of Hox
genes and it highlights the unexpectedly complex relation-
ship between the polycomb and trithorax machinery. It is
clear that these systems cannot simply be considered as op-
posing repression versus activating protein complexes.
MATERIALS AND METHODS
Cell culture
Psip1−/− and correspondingWT immortalized MEFs (30)
were a gift of Prof. Alan Engelman. Primary MEFs were
derived from 13-day-old (E13) Psip1gt/gt embryos and their
WT littermates as described previously (28). Psip1−/−
MEFs were transduced with retroviral vectors containing
p52 and p75 cDNAs -pLPX-p52HA and pLPX-p75HA
(30) and packaged in PLAT-E cells according to a stan-
dard protocol (Clonetech). Transduced cells were selected
with 2.5 g/ml puromycin and stably expressed HA-tagged
Psip1 isoformswere detected by immunoblottingwith Psip1
antibodies (Bethyl lab. A300–847).
Lentiviral knockdown
Lentiviral micro RNA (Gift from Dr. Gijsbers, KU Leu-
ven) specifically targeting p75, or both p52 and p75, iso-
forms of Psip1 were transduced into wild-type (WT)MEFs.
Stably transducedMEFs were selected using blasticidin (10
g/ml). The efficiency of knockdown was validated by im-
munoblotting with antibodies recognizing Psip1 p52 or p75
(28). Psip1 p75 was also depleted in 10.5 dpc mouse distal
posterior limb cells (36) using lenti-viral shRNAs (Sigma
Aldrich, TRCN0000012116 and TRCN0000012113) and
stably transduced cells were selected using puromycin (3
g/ml).
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described (28), using
antibodies for Psip1/p75 (Bethyl laboratory A300–848),
Psip1/p52 (Bethyl laboratory A300–847) Mll1 (Active Mo-
tif 61295), BMI1 (Millipore 05–637), Ring1B (MBLD139–
3), H3K4me3 (Millipore 07–473), menin (Abcam, ab4452–
50), RNA PolII Ser2p (Millipore 04–1571, Clone 3E10),
Ctbp1 (Santa Cruz SC-55502), CBX4 (Abcam ab139815)
and Mll2 (Abcam ab15962). ChIPed DNA was ampli-
fied with WGA2 using the manufacturer’s protocol (Sigma
Aldrich) and hybridized to custom Hox arrays (28). All
ChIP on chip experiments were done with at least two bi-
ological replicates (GEO accession number GSE 49182 for
platform GPL13276).
Normalization and analysis of microarray data was as
described previously (28). For CpG analysis, CpG islands
(CGIs) were identified by finding probes with a minimum
of 25 bp overlap with CGI found ±1 kb within genes using
Galaxy software. CGI positions were taken from the Uni-
versity of California Santa Cruz (UCSC) table browser.
Enrichment analysis for ChIP and run-on data was per-
formed for probes±1 kb from transcription start sites (TSS)
or transcription end site (TES). The smoothed conditional
mean plots were generated using the R package ggplot2 and
the geom smooth function.
The following mm9 coordinates were used for quantifica-
tion of ChIP enrichment; non-expressed 3′ Hoax(Hoxa1 to
Hoxa7) genes chr6:52,101,011–52,172,728, expressed
5′ Hoxa genes (Hoxa9-Hoxa13) chr6:52,171,296–
52,211,033, 3′ non-expressed Hoxd (Hoxd1 to Hoxd9
genes) chr2:74,534,258–74,606,421, expressed 5′ Hoxd
genes (Hoxd9-Hoxd13) chr2:74,484,916–74,537,448. To
test the significance of differential ChIP enrichment at
genomic regions a Wilcoxon rank-sum test was performed
with a correction for multiple testing (Holm method) using
the R statistical program.
For sequential ChIP (SeqChIP), antibodies were cova-
lently coupled to Dynabeads with antibody coupling kit,
(Invitrogen Cat. 14311D), using the manufacture’s proto-
col. The first ChIP was eluted with 10 mM DTT and the
elute was diluted 30 times withRadio-Immunoprecipitation
Assay (RIPA) (50 mMTris, pH 7.5, 150 mMNaCl, 1%
IGEPALCA-630, 0.5% deoxycholate) buffer before contin-
uingwith the secondChIP. Primers used for ChIP qPCRare
given in Supplementary Table S1.
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Expression analysis
Expression microarray was performed with four biological
replicates of WT and, Psip1−/− MEFs, as described pre-
viously (37). Gene Ontology (GO; Biological Process) en-
richment analysis was performed using the GO enrichment
analysis and visualization web tool (GORilla). A False Dis-
covery Rate (FDR) q-value cut-off of 0.01 was used to select
significantly enriched GO terms.
For reverse transcriptase-polymerase chain reaction (RT-
qPCR), cDNAs were prepared with Superscript II (Invitro-
gen) reverse transcriptase using random primers. The list of
specific primers used is given in Supplementary Table S1.
RT-qPCR was done with three biological replicates ofWT
and Psip1−/− MEFs and Psip1−/−MEFs rescued with p52-
HA or p75-HA cDNA on a LightCycler 480 (Roche Diag-
nostics). Data were normalized toGapdh and the error bars
indicate standard error of mean (s.e.m.) from three biologi-
cal replicates. Similarly, RT-qPCR for WT MEFs depleted
for Psip1 isoforms was done for three biological replicates.
Run-on transcription
Approximately 107 MEFs were resuspended in hypotonic
buffer (20 mM Hepes-KOH pH 7.9, 10 mMKCl, 1 mM
MgCl2, 0.5% NP40, 20% Glycerol) and dounced 25 times
on ice. The run-on transcription assay was performed as
described previously (38). Run-on RNA was reverse tran-
scribed using whole transcriptome amplification (WTA2)
kit according to the manufacturer (Sigma Aldrich), and
the resultant cDNA was labeled with Cy3 or Cy5 and hy-
bridized to the same custom tiling arrays used for hybridiz-
ing ChIP DNA.
Nuclear extracts and immuno-precipitations
Cells from 14-cm dishes were trypsinized and pelleted, re-
suspended in 5ml of ice-cold swelling buffer (10mMHepes,
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, and
protease inhibitors) for 5 min, and broken open to release
nuclei using a pre-chilled Dounce homogenizer (20 strokes
with a tight pestle). Nuclei were pelleted by centrifugation
at 228 g for 5 min at 4◦C and resuspended in 1 ml of RIPA
buffer and protease inhibitors + Benzonase (Novagen; final
concentration, 1.25 U/l) and incubated for 30 min on ice.
Extracts were cleared by centrifugation at 15500 g for 10
min at 4◦C.
Protein A Dynabeads (Invitrogen), were incubated with
5 g of  HA antibodies (for HA pulldown) or control
immunoglobulin G (IgG) antibodies for 1 h in phosphate
buffered saline. Equivalent nuclear protein amounts were
incubated with the beads coupled to antibodies for 1 h. Af-
ter 4 wash steps in RIPA buffer, bound proteins were eluted
using 2× sodium dodecyl sulphate (SDS) loading buffer,
and separated on a NuPAGE gel, blotted to Polyvinylidene
fluoride (PVDF) membrane, and immunoblotted with an-
tibodies recognizing; Mll1 (Active Motif 61295, 1:1000),
BMI1 (Millipore 05–637, 1:1000), Ring1B (MBL D139–3,
1:2000), EZH2 (BDBiosciences 1:3000) andHA tag (Sigma
H6908, 1:1000). For the GFP trap experiment, WT MEFs
were stably transduced with green fluorescent protein-p75
(GFP-p75) (39), GFP-p75 complex was purified according
to the manufacturer’s protocol (ChromoTek).
RESULTS
Psip1/p75 localizes to expressed Hox genes
Surviving Psip1 gene-trap mutant mice show homeotic
skeletal transformation phenotypes, similar to those of
Hoxa4, 5 and 6mutant animals (26).Moreover, knockdown
of PSIP1 in human cells showed that mRNAs of 5′HOXA
genes, but not genes of the other HOX loci, are among
the most up-regulated (26,40). This suggests that theHoxA
cluster may be a specific target for regulation by Psip1.
To identify Psip1/p75 occupancy on Hox loci we per-
formed ChIP for endogenous p75 from WT immortalized
MEFs with an antibody (A300–848), whose specificity for
Psip1/p75 and inability to recognize the p52 Psip1 isoform
we have confirmed previously (28). ChIP’d DNA was hy-
bridized to custom arrays covering all four Hox loci and
several other developmental genes (28). Psip1/p75 was en-
riched over HoxA and HoxD (Figure 1B) but was not de-
tected at HoxB or HoxC loci in these cells (Supplementary
Figure S1A). The preference for p75 occupancy overHoxA
and D clusters does not reflect an intrinsic property of the
DNA sequence there: ChIP in independent primary MEFs
derived in our laboratory (28) showed specific occupancy of
p75 over Hoxa, b and c genes which are expressed in those
cells (data not shown), suggesting that Psip1/p75 generally
binds to expressed Hox genes.
We found that the distribution of Mll1 and menin across
HoxA and HoxD was highly similar to that of p75 (Spear-
man’s correlation between p75 and Mll1 ρ = 0.82, P <
0.01) (Figure 1B–D) and, like p75, these proteins were also
not detected at HoxB and HoxC clusters in these MEFs
(Supplementary Figure S1A). Psip1 p75, Mll1, menin and
H3K4me3 were abundant at the 5′ ends ofHoxA andHoxD
(Hoxa9 to a13, Hoxd10 to d13) but not at the 3′ end (Fig-
ure 1B). Mll1 and p75 were also not enriched at the silent
non-Hox polycomb-targetShh gene (Supplementary Figure
S1B and C).
AtMyc, p75 is present at the 3′ end of this active gene, as
has been seen more globally for Psip1/p52 (Supplementary
Figure S1B and C), consistent with targeting to H3K36me3
via the PWWPdomain common to both Psip1 isoforms (28)
(Figure 1C and D). Mll1 and Menin have a broad distribu-
tion across Myc, suggesting Psip1 independent binding at
this locus (Supplementary Figure S1C).
At 5′Hoxa and 5′Hoxd genes we found that, like p75,
Mll1 is partially excluded from CGIs (Figure 1D and E)
but is enriched∼1 kb downstream from the TSSs, over gene
bodies particularly near TESs and beyond (Figure 1C and
D). This is a similar profile to that ofH3K36me3 (Figure 1C
and D) (28) and is consistent with previous analysis of Mll1
distribution over late HOXA genes in a human lymphoma
cell line (41). This suggests that Mll1 recruitment to chro-
matin may be dependent on its interaction with Psip1 and
not binding of its CXXC domain to unmethylated CGIs.
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Figure 1. Psip1/p75, Mll1 and menin localization in wild-type and Psip1−/− cells. (A) Cartoon of Psip1 p52 and p75 isoforms showing the localization
of the PWWP domain, AT hooks and also the integrase binding domain (IBD) domain at the C-terminus of p75 that interacts with menin and Mll1.
The menin binding domain (MBD), Psip1 binding domain (PDB), CxxC domain and plant homeodomain (PHD) of Mll are also shown. (B) Mean Log2
ChIP/input for Psip1/p75 Mll1, Mll2, menin and H3K4me3 in WT and Psip1−/− MEFs over genomic regions encompassing HoxA (left) and HoxD loci
(right). For Mll1, a difference plot for Mll1 ChIP in Psip1−/− versus WT cells is also shown. (n = 2 biological replicates.) Below, the positions of CpG
islands and genes are shown. Genome co-ordinates (bp) from the mm9 version of the mouse genome assembly. (C) Averaged Log2 ChIP/input ratios
for p75 (black lines), Mll1(green) and H3K36me3 (red) in 2 kb windows surrounding the transcription start site (TSS) or transcription end site (TES) of
expressed genes from the 5′ portions of Hoxa and Hoxd. Arrow under TSS indicates the direction of transcription. (D) As in B, but zoomed in view of
Psip1/p75, Mll1 and H3K36me3 distributions over Hoxa9 and Hoxa10 in WT MEFS. The Mll1 distribution in Psip1−/− MEFs is also shown. (E) Box
plots showing the distribution of Log2 ChIP/input ratios for Psip1/p75 (top) and Mll1 (bottom) over the CpGisland (CGI) and non-CGI portions of
expressed non-Hox genes and expressed genes from 5′ HoxA and HoxD.
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Psip1 is required forMll1 recruitment to expressedHoxA and
HoxD
The co-occurrence of Mll1 and Psip1/p75 are consistent
with Psip1 being required to tether Mll1 at target genes
(32). To test this, we performed ChIP for Mll1, Menin and
H3K4me3 in Psip1 homozygous null MEFs (Psip1−/−) de-
rived frommutant embryos that were littermates to theWT
controls (28,30). There were not extensive changes in Mll1
or menin binding at non Hox genes in the mutant MEFs
(Figure 2).However, loss of Psip1 significantly (P< 0.01) re-
ducedMll1 binding across 5′ Hoxa (a9-a13) - andHoxd (d9-
d13) genes (Figures 1B and 2A). Menin levels were not re-
duced (Figure 2C). Surprisingly, H3K4me3 levels were also
not significantly changed at either 5′ HoxD or HoxA (Fig-
ures 1B and 2D) in the absence of Psip1, suggesting that
Mll1 is dispensable for this histone modification at these
sites.
To confirm that loss of Mll1 in Psip1−/−MEFs is not
due to differences in cell types, we repeated the Mll1 ChIP
in limb mesenchyme cells (36) specifically depleted for
Psip1/p75 with a short-hairpin (Sh) RNA. Mll1 was signif-
icantly reduced overHox genes in the p75 knockdown cells
compared to controls. The p52 isoform of Psip1 was not
ablated by the p75 ShRNA (Supplementary Figure S1D),
confirming that it is indeed Psip1/p75 that is required for
Mll1 targeting.
Both Mll1 and Mll2 are implicated in regulating Hox
genes (5) and although a direct interaction between p75 and
Mll2 has not been demonstrated, a recent report (42) and
our GFP-p75 trap data, see below, indicate the presence of
Mll2 with p75 complexes, possibly through the common in-
teractor Menin (25). Indeed, we detected Mll2 over both
HoxA and D loci inWTMEFs (Figure 1B) and Mll2 levels
were significantly reduced over 5′Hoxa and Hoxd genes in
Psip1−/− MEFs (Figure 2B).
Absence of Psip1/p75 leads to mis-expression of Hox genes
Microarray analysis shows elevated levels of mRNAs from
several 5′ Hoxa and Hoxd genes in Psip1−/− MEFs com-
pared to WT cells (Figure 3A) and, surprisingly, given
the usual association of Trx proteins with gene activa-
tion, this included 5′ Hoxa genes (a9, a10 and a11), that
lose Mll1 binding in the mutant cells. This was con-
firmed by quantitative RT-PCR (Figure 3B). GO analy-
sis of genes differentially expressed (FDR q < 0.01) be-
tween WT and Psip1−/−show enrichment of terms associ-
ated with anatomical structure morphogenesis and devel-
opmental process (Supplementary Figure S2A), consistent
with the craniofacial and skeletal abnormalities of surviving
Psip1 mutant mice (26).
To test whether mis-regulation is due to loss of the p52 or
p75 Psip1 isoforms, we rescued each isoform by retroviral
transduction of appropriate cDNAs into Psip1−/− MEFs
(Figure 3C). Psip1 p75 was able to reverse the elevated
mRNA levels of many of the up-regulatedHoxa genes, and
p52 had modest or no effects on expression of the tested
genes, with the exception of Hoxa7 (Figure 3B).
We further confirmed a direct effect of p75 loss on Hoxa
mRNAs by knocking down Psip1/p75 protein levels inWT
MEFs using two different miRNAs, one specific for the p75
isoform and that has no effect on Psip1/p52, and the other
targeting the N-terminal domain common to both isoforms
(Figure 3E). This resulted in increased expression ofHoxa9-
a13, andHoxd9-d13mRNAs (Figure 3D). Steady-state lev-
els of mRNAs from 3′ Hox (a2-a4) were unaltered, com-
patible with data from Psip1−/− cells (Figure 3A and B).
Elevated 5′ HoxamRNA levels, was also validated in pri-
mary MEFs derived from E13.5 Psip1gt/gt embryos com-
pared to their wild-type littermates (26,28) (Supplementary
Figure S2B). Together, these data suggest that Psip1 p75
has a specific role in regulating the expression level of Hox
genes.
Given our previous demonstration of a role for Psip1
p52 in mRNA processing (28) we determined whether Psip
p75 affected the level of transcription per se. Run-on tran-
scription inWTMEFs detected high nascent RNA synthe-
sis from the 5′ ends of the HoxA and HoxD clusters, and
not from the 3′ regions (Figure 3F). In Psip1−/− cells, run-
on RNA levels were elevated at 5′ Hoxa and Hoxd genes,
but not at non-Hox genes or intergenic regions, or at the
3′ end of HoxD (Figure 3F and G, Supplementary Figure
S2C). Intriguingly, elevated nascent RNAwas also detected
over part of the 3′ end of HoxA, even though there is no
Psip1/p75 bound at this region and no change in levels of
maturemRNA fromHoxa4 is detected inPsip1mutant cells
(Figure 3A and D). However, we note that the extent of
this transcription corresponds to the large annotatedHoxa3
transcript whose TSS is located toward the 5’ of Hoxa, be-
tween Hoxa6 and Hoxa7. This signal may also arise from
unstable, unprocessedRNA.We also noted slightly elevated
levels ofMenin andH3K4me3 at 3′HoxA in themutant cells
though this increase was not statistically significant (Fig-
ures 1B and 2C and D).
Our data are consistent with Psip1 playing some role in
regulating transcription ofHox genes. Furthermore, the en-
richment of p75 on gene bodies and toward the TES of
transcribed Hoxa genes (Figure 1B–D), together with di-
rect binding to H3K36me3 (28), suggests that Psip1 could
function to regulate transcription elongation. To investigate
this we examined the levels of the elongating serine 2 phos-
phorylated form of RNA polymerase II (PolII S2p) (43,44)
by ChIP in WT and Psip1 mutant cells. The levels of PolII
S2p were significantly elevated across HoxA and HoxD in
Psip1−/− cells (Figure 3F and G). Levels of the serine 5
phosphorylated initiating formof PolII (PolII S5p) were not
changed. These data suggests that Psip1/p75 functions to
restrain the elongation of transcription from paused/poised
Pol II at Hox loci and that this may operate through Mll1
retention––at least for 5′ genes of the cluster.
Absence of Psip1 leads to loss of Bmi1 and Ctbp1
To further investigate the mechanism through which Psip1
andMll1 restrict expression fromHox genes, we performed
a GFP trap experiment using stably expressed GFP-p75 in
WTMEFs. Consistent with previous studies (8,32) andwith
our ChIP analyses, Mll1 andMll2 were detected interacting
with Psip1. Given the known role of the PRCs in repressing
Hox gene expression via paused polII (44) and in antago-
nizing trithorax, we looked for members of the PRC1 and
PRC2 complexes in the proteins pulled down with GFP-
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Figure 2. Psip1 loss results in reduced Mll1 and Mll2 at Hox loci. Box plots showing the distribution of; (A) Mll1, Psip1/p75, (B) Mll2 (C) menin and
(D) H3K4me3 inWT (black boxes) and Psip1−/− (gray boxes) cells at expressed non-Hox genes, 3′ Hoxa genes (Hoxa1-a7), 5′ Hoxa genes (Hoxa9-a13),
3′ Hoxd genes (Hoxd1-d9) and Hoxd10-d13. Regions with a statistically significant (P < 0.01) difference in binding between WT and Psip1−/− cells as
assessed with a Wilcoxon rank-sum test are indicated with an asterisk (*). Box plots showing the distribution of Psip p75 are also shown in (A).
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Figure 3. Psip1/p75 represses the expression of Hox genes. (A) Log2 fold change in mean (+/- s.e.m) microarray expression levels of Hoxa and Hoxd
genes in Psip1−/− versus WT (n = 4 biological replicates each). (B) Mean (+/- s.e.m.) expression of Hoxa genes, normalized to Gapdh, assayed by RT-
qPCR, in WT (white) and Psip1−/− (dark gray) cells, and in Psip1 mutant cells rescued with p52 (light gray) or p75 (black bars) Psip1 isoforms (n = 3
biologial replicates). (C) Immunoblot to detect p75 and p52 Psip1 isoforms in WT, Psip1−/−, p52 rescue, and p75 rescue cells. Pcna served as loading
control. (D) Mean (+/- s.e.m.)Hoxa and Hoxd gene expression, normalized to Gapdh, inWTMEFs after specific knockdown of p75 isoform (gray bars),
or both p52 and p75 isoforms of Psip1 (black bars) and a control scrambled micro-RNA (white bars). (E) Immunoblot to detect p75, p52 and Pcna in cells
transfected with control, p75-specific, and p52 + p75 isoform specific lentiviral micro-RNAs. (F) Top: Mean log2 signal of run-on transcribed RNA from
WT and Psip1−/− MEFs over HoxA (left) and HoxD (right), established by hybridization of cDNA from run-on transcripts to custom tiling arrays. (n =
3, 2 biological and 1 technical replicates). A difference plot for Psip1−/−versus WT cells is also shown. Bottom: Mean Log2 ChIP/input for Ser2 (S2p)
and Ser5 (S5p) phosphorylated PolII in WT and Psip1−/− MEFs (n = 2 biological replicates). (G) Box plots show: Top––Log2 ratio of Psip1−/−/WT
run-on transcribed RNA (Nascent RNA) over non Hox genes, genes from the 3′ and 5′ ends ofHoxA and HoxdD, and intergenic regions. Bottom––Log2
ChIP/input for Ser2 phosporylated RNA Polymerase II (Pol II (S2p) in WT and Psip1−/− MEFs over non-Hox genes, Hoxa genes, Hoxd genes and
intergenic regions (n = 2 biological replicates). Regions with a statistically significant difference (P < 0.05) in S2p between WT and Psip1−/− cells as
assessed by the Wilcoxon rank-sum test are indicated with an asterisk (*).
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p75 (Figure 4A). We detected no Ezh2, the HMTase from
PRC2, nor did we detect Mel18 from PRC1 or Rybp––a
member of a non-canonical PRC1 complex (45–47). How-
ever, we did detect the PRC1 components Bmi1 and Cbx4.
Interestingly, Ctbp1 a transcriptional co-repressor was also
detected in the GFP-p75 trap. Interactions amongst Mll1,
Bmi1 and Psip/75, but not p52, were confirmed by pull-
down of HA-tagged Psip1 isoforms (Supplementary Fig-
ure S3A). Not all PRC1 members interact with Psip1/Mll1
complex––Ring1B, a core member of PRC1 was not de-
tected (Supplementary Figure S3A).
Bmi1, Ctbp1 and Cbx4 have been previously shown to
interact directly with the CxxC domain of Mll1 (48). These
data prompted us to investigate the occupancy of these, and
other polycomb-associated proteins, in WT and Psip1−/−
MEFs. Bmi1, and Ring1B were detected at HoxA and D
clusters, even over transcribed genes in WT MEFs (Fig-
ure 4B). Like Psip1 and Mll1, Cbx4 and Ctbp1 were en-
riched at the expressed 5′ Hoxa and d genes and not the 3′
regions of these clusters. The absence of Psip1 in mutant
MEFs had no significant effects on Bmi1, Cbx4 andRing1B
levels at non-expressed HoxB and C (Supplementary Fig-
ure S3B), or at non-Hox genes (Figure 4C). However, Psip1
absence led to significant loss of Bmi1 and Ctbp1 over 5′
HoxA and D (Figure 4B and C). We also note that there is
some reduction of Bmi1 detected at 3′ HoxA andD in Psip1
mutant cells but this does not reach statistical significance.
Ctbp1 is not present at these regions even in wild-type cells.
To verify co-occupancy of Psip1/Mll1 and Bmi1 over tar-
get genes, we performed sequential ChIP, first using co-
valently coupled IgG, p75 and Mll1 antibodies and then
the second ChIPs done with antibodies recognizing Bmi1.
In WT MEFs, we detected high co-occupancy of p75 with
Bmi1, as well as Mll with Bmi1, over the promoter, exon1
and exon2 of Hoxa9 (Figure 4D). In Psip1−/− MEFs, p75-
Bmi co-occupancy was eliminated and Mll/Bmi1 occu-
pancy greatly reduced (by 50–80%).
To confirm a direct role for Psip1 in Bmi1 retention at 5′
HoxA we performed ChIP for Bmi1 and Psip1/p75 in WT
and Psip1−/− MEFs, and in Psip1−/− cells rescued with the
p75 isoform. qPCR showed restoration of Bmi1 levels over
tested Hoxa genes after p75 rescue (Figure 4E). A version
of p75 in which a critical residue in the PWWP aromatic
cage involved in H3K36me3 binding is mutated (W21A)
(49) failed to restore Bmi1 binding (Figure 4E) and indeed
W21A p75 failed to bind toHox loci, consistent with a role
for H3K36me3 recognition in p75 targeting (28).
DISCUSSION
It is generally assumed that members of polycomb com-
plexes are involved in gene repression and that trithorax
group members counteract this and help to maintain an ac-
tive state (6–8). Here we have demonstrated that Psip1/p75
is required to retain Mll1/2 and Bmi1/Ctbp1 at HoxA and
HoxD loci (Figures 1 and 2), with the net result of damp-
ened gene expression. Contrary to the assumed role of Mll1
inmaintaining gene activity, the loss ofMll1 (andMll2) that
occurs in the absence of Psip1 results in the upregulation
of Hoxa and Hoxd gene transcription and mRNA levels.
These data that we obtained in mouse embryonic fibrob-
lasts are consistent with the upregulation ofHox genes that
was reported after knockdown of PSIP1 in human 293 cells
(26,40).
Psip1, Mll and menin
Menin has been reported to be important for MLL1/2 re-
cruitment to target genes and forHox gene regulation (22).
Menin was suggested to bind toMLL1 and to interact with
Psip1/p75 using distinct interaction surfaces (23–25) (32).
Levels of Menin were not significantly changed in Psip1−/−
cells suggesting that Psip1 is not required for menin target-
ing (Figure 2).
In MEFs we found similar genomic binding profiles for
Psip1/p75, Mll1 and Mll2 (Figure 1) and in the absence of
Psip1, Mll1/2 levels were reduced over expressed (5′) genes
of the HoxA and HoxD clusters. However, we found no
corresponding loss of H3K4 trimethylation suggesting that
Mll1/2 are dispensable for H3K4me3 at these loci. Our data
are consistent with persistence of H3K4me3 over someHox
genes in both Mll1−/− and Mll2−/− ES cells (18) and in
Mll1−/− MEFs (5) and the suggestion that multiple H3K4
HMTs, including SET1, can be found co-bound at the same
active genes (18).
Psip1 and Hoxa gene expression
PSIP1, and particularly its PWWP domain, is known to be
required for MLL1-mediated leukemogenesis, and for tar-
geting MLL1 fusion partners leading to uncontrolled ex-
pression ofHOXA9 in leukemia (32). Similarly, Psip1 gene-
trap mutant (Psip1gt/gt) mice have posterior skeletal trans-
formations (26), similar to mice with mutation of Hoxa
genes (50–52).
Here, we have demonstrated specific up-regulation of
mRNA expression from 5′ genes of the HoxA and HoxD
clusters (Figure 3) in the absence of Psip1 and have shown
that this is dependent on the long p75 isoform of Psip1 and
not p52––which we have previously demonstrated interacts
with splicing factors to modulate alternative splicing (28).
Consistent with recognition of H3K36me3 by the PWWP
domain of Psip1 (28,49), p75 is distributed away from CGIs
and toward the 3′ end ofHox genes (Figure 1).We show that
the Psip1 PWWP domain is required for Bmi1 recruitment
to 5′ HoxA and HoxD (Figure 4).
Psip1 and the interplay between polycomb and trithorax reg-
ulation
Our results suggest that Psip1/p75 functions to recruit Mll,
and yet to restrain expression, from specificHox loci. Clues
to the mechanism underlying this may arise from our ob-
servation that Psip1 is also needed to recruit the repressors
Bmi1 and Ctbp1 (Figure 4). We therefore suggest that at
HoxA and HoxD, Psip1 tunes gene expression through its
ability to recruit both Mll1 and Bmi1/Ctbp1.
Mll1 is a large multidomain protein that, by binding dif-
ferent proteins, can act either as a transcriptional activator
or a repressor. Bmi1 has been reported to bind to the repres-
sive (CxxC) domain of Mll1 (48) and we have confirmed
that Bmi1 is present in chromatin that also contains Mll1
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Figure 4. Loss of Psip1 leads to reduced Bmi1 and Ctbp1 on target genes. (A) Psip1/p75 complexes purified from stably transduced GFP-p75, and GFP
(control) cells, and immunoblotted using antibodies against Mll1, Mll2, Bmi1, Ctbp1, Cbx4, Ezh2, Mel18, Rybp and Pcna. Note that 5% input extract
were also loaded. (B) Mean Log2 ChIP/input for Bmi1, Cbx4, Ring1B and Ctbp1 inWT and Psip1−/− MEFs over HoxA (left) andHoxD clusters (right)
using custom tiling arrays as in Figure 1. (C) Box plots showing Log2 ChIP/input distributions for Bmi1, Ctbp1, Cbx4 and Ring1B in WT and Psip1−/−
MEFs over 5′ and 3′ regions ofHoxA andHoxD clusters, and non-Hox genes (n = 2 biological replicates). Asterisk (*) indicates a significant difference in
ChIP/input signal between WTand Psip1−/−(P < 0.01, Wilcoxon rank-sum test). (D) Sequential-ChIP qPCR over promoter (Hoxa9p), exon1 (Hoxa9E1)
and exon 2 of Hoxa9 (Hoxa9E2) in Psip1 WT and Psip1−/− MEFs. First, ChIP was performed with covalently coupled IgG (IgG-Bmi1), p75 (p75-Bmi1)
and Mll1 (Mll1-Bmi1), followed by Bmi1 antibodies for second ChIP. Schematic below shows the Hoxa9 gene and primers used for PCR. (E) ChIP qPCR
for Bmi1 and p75 in WT (green) and Psip1−/− (orange) MEFS, and inPsip1−/− rescued with WT p75 (Psip1−/−p75 R; black) or p75 with W21A PWWP
point mutation (Psip1−/−p75 W21A R; gray). Ptn promoter primers (Ptnp) were used as a control. Mean (+/- s.e.m.) percent (%) input bound (n = 3) are
plotted.
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(Figure 4). Supporting a functional link between Psip1 and
Bmi1, the up-regulation of 5′ Hoxa genes inPsip1−/− cells is
similar to that seen in Bmi1−/− MEFs (53) and Psip1 gene-
trap mutant (Psip1gt/gt) mice have posterior skeletal trans-
formations (26) similar to mice with mutation of Bmi1 (54).
The HMTase activity of Mll1 is known to be dispens-
able for its essential functions (16). Since we show that
H3K4me3 levels are not altered over 5′Hoxa genes in the
absence of Psip1 and loss ofMll1 binding (Figures 1 and 2),
we suggest that the Psip1-Mll1 interaction serves to recruit
repressors, including the Bmi1 component of PRC1 and the
co-repressor Ctbp1. Ctbp1 has been reported to colocalize
with Bmi1 in the nucleus (55) and mutation of Ctbp1 in
flies leads to loss of polycomb group protein recruitment
to polycomb response elements (PREs) (56). Similarly, the
increased expression of Hoxd genes reported in Mll1−/−
MEFs (5) could be due to loss of repressors, such as Bmi1
and Ctbp1. Psip1 has been shown to promote homologous
recombination (HR) by interacting with CtIP (29), CtIP in-
teracts with CtBP1 and both proteins are components of
the RBP-J/SHARP corepressor complex (57). Recently, a
role for H3K36me3 and Psip1 in promoting HR at tran-
scriptionally active loci has been demonstrated (58), which
is consistent with the recruitment of Psip1 to expressed gene
bodies marked by H3K36me3 (28).
We have identified a new Psip1-dependent pathway of
control of Hox loci that involves both repressors (Bmi1,
Ctbp1) and proteins traditionally thought to be involved in
maintaining gene activation (Mll1/2). This appears to oper-
ate, at least partially, at the level of transcription elongation
(Figure 3), but we do not exclude that there may be effects
at other levels of RNA processing as well. The polycomb
and trithorax systems are usually considered to be antag-
onistic repressive and activating protein complexes. How-
ever, the colocalization of both Trx and polycomb at spe-
cific sites on Drosophila polytene chromosomes hints at an
interaction between the two systems (59). Other studies have
also indicated the presence of repressor complexes at active
loci and their role in ‘fine-tuning’ of gene activation (60).
Occurrence of proteins known to be implicated with gene
repression––e.g. Bmi1, Ctbp1, CBX4 and Ring1B over the
expressed Hox genes (Figure 4), and up-regulation of mR-
NAs fromHox genes with the loss of some of these proteins,
suggests amore nuanced role of these proteins in fine tuning
gene expression.
Finally, our data suggests a new pathway of gene control
thatmay be important for the dysregulation ofHOXA genes
in leukemia (61). MLL is required to maintain HOXA9 ex-
pression in haematopoietic progenitor cells, but then is also
required to later repress HOXA9 during the later stages of
differentiation (62). Moreover, acute and chronic myeloid
leukemias and myelodysplastic syndrome have been associ-
ated with fusion of PSIP1 to NUP-98 (63–65).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Prof. Alan Engelman (Harvard Medical School)
forPsip1−/− MEFs andPsip1/p52 and Psip1/p75 retroviral
rescue plasmids, Dr. Rik Gijsbers (KU Leuven) for Psip1
knockdown and GFP-p75 lentiviral vectors and Prof. Jay
Hess (The University of Michigan) forMll1−/− MEFs.
FUNDING
Medical Research Council UK and Wellcome Trust
[WT085767]. Source of open access funding: MRC Univer-
sity Unit programme grant (University of Edinburgh).
Conflict of interest statement.None declared.
REFERENCES
1. Soshnikova,N. and Duboule,D. (2009) Epigenetic temporal control of
mouse Hox genes in vivo. Science, 324, 1320–1323.
2. Shen,X., Liu,Y., Hsu,Y.-J., Fujiwara,Y., Kim,J., Mao,X., Yuan,G.-C.
and Orkin,S.H. (2008) EZH1 mediates methylation on histone H3
lysine 27 and complements EZH2 in maintaining stem cell identity
and executing pluripotency.Mol. Cell, 32, 491–502.
3. Eskeland,R., Leeb,M., Grimes,G.R., Kress,C., Boyle,S., Sproul,D.,
Gilbert,N., Fan,Y., Skoultchi,A.I., Wutz,A. et al. (2010) Ring1B
compacts chromatin structure and represses gene expression
independent of histone ubiquitination.Mol. Cell, 38, 452–464.
4. Milne,T.A., Briggs,S.D., Brock,H.W., Martin,M.E., Gibbs,D.,
Allis,C.D. and Hess,J.L. (2002) MLL targets SET domain
methyltransferase activity to Hox gene promoters.Mol. Cell,
10, 1107–1117.
5. Wang,P., Lin,C., Smith,E.R., Guo,H., Sanderson,B.W., Wu,M.,
Gogol,M., Alexander,T., Seidel,C., Wiedemann,L.M. et al. (2009)
Global analysis of H3K4 methylation defines MLL family member
targets and points to a role for MLL1-mediated H3K4 methylation in
the regulation of transcriptional initiation by RNA polymerase II.
Mol. Cell. Biol., 29, 6074–6085.
6. Klymenko,T. and Mu¨ller,J. (2004) The histone methyltransferases
Trithorax and Ash1 prevent transcriptional silencing by Polycomb
group proteins. EMBO Rep., 5, 373–377.
7. Poux,S., Horard,B., Sigrist,C.J. and Pirrotta,V. (2002) The Drosophila
trithorax protein is a coactivator required to prevent re-establishment
of polycomb silencing. Development, 129, 2483–2493.
8. Tanaka,Y., Kawahashi,K., Katagiri,Z.-I., Nakayama,Y., Mahajan,M.
and Kioussis,D. (2011) Dual function of histone H3 lysine 36
methyltransferase ASH1 in regulation of Hox gene expression. PLoS
One, 6, e28171.
9. Schuettengruber,B., Martinez,A.-M., Iovino,N. and Cavalli,G. (2011)
Trithorax group proteins: switching genes on and keeping them
active. Nat. Rev. Mol. Cell Biol., 12, 799–814.
10. Shilatifard,A. (2012) The COMPASS family of histone H3K4
methylases: mechanisms of regulation in development and disease
pathogenesis. Annu. Rev. Biochem., 81, 65–95.
11. Lee,J.-H. and Skalnik,D.G. (2005) CpG-binding protein (CXXC
finger protein 1) is a component of the mammalian Set1 histone
H3-Lys4 methyltransferase complex, the analogue of the yeast
Set1/COMPASS complex. J. Biol. Chem., 280, 41725–41731.
12. Wu,M., Wang,P.F., Lee,J.S., Martin-Brown,S., Florens,L.,
Washburn,M. and Shilatifard,A. (2008) Molecular regulation of
H3K4 trimethylation by Wdr82, a component of human
Set1/COMPASS.Mol. Cell. Biol., 28, 7337–7344.
13. Cho,Y.-W., Hong,T., Hong,S., Guo,H., Yu,H., Kim,D.,
Guszczynski,T., Dressler,G.R., Copeland,T.D., Kalkum,M. et al.
(2007) PTIP associates with MLL3- and MLL4-containing histone
H3 lysine 4 methyltransferase complex. J. Biol. Chem., 282,
20395–20406.
14. Dharmarajan,V. and Cosgrove,M.S. (2011) Biochemistry of the
mixed lineage leukemia 1 (MLL1) protein and targeted therapies for
associated leukemia. In: Antica,Mariastefania (ed). Acute Leuk. -
The Scientist’s Perspective and Challenge In Tech.
15. Yu,D.B., Hess,J.L., Horning,S.E., Brown,G.A. and Korsmeyer,S.J.
(1995) Altered Hox expression and segmental identity in Mll-mutant
mice. Nature, 378, 505–508.
16. Terranova,R., Agherbi,H., Boned,A., Meresse,S. and Djabali,M.
(2006) Histone and DNA methylation defects at Hox genes in mice
 at A
lbert Slom
an Library, U
niversity of Essex on O
ctober 16, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2014, Vol. 42, No. 14 9031
expressing a SET domain-truncated form of Mll. Proc. Natl. Acad.
Sci. U.S.A., 103, 6629–6634.
17. Hu,D., Garruss,A.S., Gao,X., Morgan,M.A., Cook,M., Smith,E.R.
and Shilatifard,A. (2013) The Mll2 branch of the COMPASS family
regulates bivalent promoters in mouse embryonic stem cells. Nat.
Struct. Mol. Biol., 20, 1093–1097.
18. Denissov,S., Hofemeister,H., Marks,H., Kranz,A., Ciotta,G.,
Singh,S., Anastassiadis,K., Stunnenberg,H.G. and
Stewart,A.F. (2014) Mll2 is required for H3K4 trimethylation on
bivalent promoters in embryonic stem cells, whereas Mll1 is
redundant. Development, 141, 526–537.
19. Tie,F., Banerjee,R., Saiakhova,A.R., Howard,B., Monteith,K.E.,
Scacheri,P.C., Cosgrove,M.S. and Harte,P.J. (2014) Trithorax
monomethylates histone H3K4 and interacts directly with CBP to
promote H3K27 acetylation and antagonize Polycomb silencing.
Development, 141, 1129–1139.
20. Bertani,S., Sauer,S., Bolotin,E. and Sauer,F. (2011) The noncoding
RNAMistral activates Hoxa6 and Hoxa7 expression and stem cell
differentiation by recruiting MLL1 to chromatin.Mol. Cell, 43,
1040–1046.
21. Wang,K.C., Yang,Y.W., Liu,B., Sanyal,A., Corces-Zimmerman,R.,
Chen,Y., Lajoie,B.R., Protacio,A., Flynn,R.A., Gupta,R.A. et al.
(2011) A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature, 472, 120–124.
22. Milne,T.A., Hughes,C.M., Lloyd,R., Yang,Z., Rozenblatt-Rosen,O.,
Dou,Y., Schnepp,R.W., Krankel,C., Livolsi,V. A, Gibbs,D. et al.
(2005) Menin and MLL cooperatively regulate expression of
cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A., 102,
749–754.
23. Yokoyama,A., Wang,Z., Wysocka,J., Sanyal,M., Aufiero,D.J.,
Kitabayashi,I., Herr,W. and Cleary,M.L. (2004) Leukemia
proto-oncoprotein MLL forms a SET1-like histone methyltransferase
complex with menin to regulate Hox gene expression leukemia
proto-oncoprotein MLL forms a SET1-like histone methyltransferase
complex with menin to regulate Hox gene expression.Mol. Cell.
Biol., 24, 5639–5649.
24. Yokoyama,A., Somervaille,T.C.P., Smith,K.S., Rozenblatt-Rosen,O.,
Meyerson,M. and Cleary,M.L. (2005) The menin tumor suppressor
protein is an essential oncogenic cofactor for MLL-associated
leukemogenesis. Cell, 123, 207–218.
25. Huang,J., Gurung,B., Wan,B., Matkar,S., Veniaminova,N.A.,
Wan,K., Merchant,J.L., Hua,X. and Lei,M. (2012) The same pocket
in menin binds both MLL and JUND but has opposite effects on
transcription. Nature, 482, 542–546.
26. Sutherland,H.G., Newton,K., Brownstein,D.G., Holmes,M.C.,
Kress,C., Semple,C.A. and Bickmore,W.A. (2006) Disruption of
Ledgf/Psip1 results in perinatal mortality and homeotic skeletal
transformations.Mol. Cell. Biol., 26, 7201–7210.
27. Ge,H., Si,Y. and Wolffe,A P. (1998) A novel transcriptional
coactivator, p52, functionally interacts with the essential splicing
factor ASF/SF2.Mol. Cell, 2, 751–759.
28. Pradeepa,M.M., Sutherland,H.G., Ule,J., Grimes,G.R. and
Bickmore,W.A. (2012) Psip1/Ledgf p52 Binds Methylated Histone
H3K36 and Splicing Factors and Contributes to the Regulation of
Alternative Splicing. PLoS Genet, 8, e1002717.
29. Daugaard,M., Baude,A., Fugger,K., Povlsen,L.K., Beck,H.,
Sørensen,C.S., Petersen,N.H.T., Sorensen,P.H.B., Lukas,C., Bartek,J.
et al. (2012) LEDGF (p75) promotes DNA-end resection and
homologous recombination. Nat. Struct. Mol. Biol., 19, 803–810.
30. Shun,M.-C., Raghavendra,N.K., Vandegraaff,N., Daigle,J.E.,
Hughes,S., Kellam,P., Cherepanov,P. and Engelman,A. (2007)
LEDGF/p75 functions downstream from preintegration complex
formation to effect gene-specific HIV-1 integration. Genes Dev., 21,
1767–1778.
31. Marshall,H.M., Ronen,K., Berry,C., Llano,M., Sutherland,H.,
Saenz,D., Bickmore,W., Poeschla,E. and Bushman,F.D. (2007) Role
of PSIP1/LEDGF/p75 in lentiviral infectivity and integration
targeting. PLoS One, 2, e1340.
32. Yokoyama,A. and Cleary,M.L. (2008) Menin critically links MLL
proteins with LEDGF on cancer-associated target genes. Cancer Cell,
14, 36–46.
33. Maertens,G.N., Cherepanov,P. and Engelman,A. (2006)
Transcriptional co-activator p75 binds and tethers the
Myc-interacting protein JPO2 to chromatin. J. Cell Sci., 119,
2563–2571.
34. Bartholomeeusen,K., Christ,F., Hendrix,J., Rain,J.-C., Emiliani,S.,
Benarous,R., Debyser,Z., Gijsbers,R. and De Rijck,J. (2009) Lens
epithelium-derived growth factor/p75 interacts with the
transposase-derived DDE domain of PogZ. J. Biol. Chem., 284,
11467–11477.
35. Cherepanov,P., Maertens,G., Proost,P., Devreese,B., Van Beeumen,J.,
Engelborghs,Y., De Clercq,E. and Debyser,Z. (2003) HIV-1 integrase
forms stable tetramers and associates with LEDGF/p75 protein in
human cells. J. Biol. Chem., 278, 372–381.
36. Williamson,I., Eskeland,R., Lettice,L.a., Hill,A.E., Boyle,S.,
Grimes,G.R., Hill,R.E. and Bickmore,W.A. (2012)
Anterior-posterior differences in HoxD chromatin topology in limb
development. Development, 139, 3157–3167.
37. Taylor,G.C.A., Eskeland,R., Hekimoglu-Balkan,B., Pradeepa,M.
and Bickmore,W.A. (2013) H4K16 acetylation marks active genes
and enhancers of embryonic stem cells, but does not alter chromatin
compaction. Genome Res., 23, 2053–2065.
38. Clouaire,T., Webb,S., Skene,P., Illingworth,R., Kerr,A., Andrews,R.,
Lee,J.-H., Skalnik,D. and Bird,A. (2012) Cfp1 integrates both CpG
content and gene activity for accurate H3K4me3 deposition in
embryonic stem cells. Genes Dev., 26, 1714–1728.
39. Hendrix,J., Gijsbers,R., De Rijck,J., Voet,A., Hotta,J., McNeely,M.,
Hofkens,J., Debyser,Z. and Engelborghs,Y. (2011) The
transcriptional co-activator LEDGF/p75 displays a dynamic
scan-and-lock mechanism for chromatin tethering. Nucleic Acids
Res., 39, 1310–1325.
40. Ciuffi,A., Llano,M., Poeschla,E., Hoffmann,C., Leipzig,J., Shinn,P.,
Ecker,J.R. and Bushman,F. (2005) A role for LEDGF/p75 in
targeting HIV DNA integration. Nat. Med., 11, 1287–1289.
41. Guenther,M.G., Jenner,R.G., Chevalier,B., Nakamura,T.,
Croce,C.M., Canaani,E. and Young,R.A. (2005) Global and
Hox-specific roles for the MLL1 methyltransferase. Proc. Natl. Acad.
Sci. U.S.A., 102, 8603–8608.
42. Van Nuland,R., Smits,A.H., Pallaki,P., Jansen,P.W.T.C.,
Vermeulen,M. and Timmers,H.T.M. (2013) Quantitative dissection
and stoichiometry determination of the human SET1/MLL histone
methyltransferase complexes.Mol. Cell. Biol., 33, 2067–2077.
43. Hsin,J.-P. and Manley,J.L. (2012) The RNA polymerase II CTD
coordinates transcription and RNA processing. Genes Dev., 26,
2119–2137.
44. Stock,J.K., Giadrossi,S., Casanova,M., Brookes,E., Vidal,M.,
Koseki,H., Brockdorff,N., Fisher,A.G. and Pombo,A. (2007)
Ring1-mediated ubiquitination of H2A restrains poised RNA
polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol., 9,
1428–1435.
45. Tavares,L., Dimitrova,E., Oxley,D., Webster,J., Poot,R., Demmers,J.,
Bezstarosti,K., Taylor,S., Ura,H., Koide,H. et al. (2012) RYBP-PRC1
complexes mediate H2A ubiquitylation at polycomb target sites
independently of PRC2 and H3K27me3. Cell, 148, 664–678.
46. Gao,Z., Zhang,J., Bonasio,R., Strino,F., Sawai,A., Parisi,F.,
Kluger,Y. and Reinberg,D. (2012) PCGF homologs, CBX proteins,
and RYBP define functionally distinct PRC1 family complexes.Mol.
Cell, 45, 344–356.
47. Morey,L., Aloia,L., Cozzuto,L., Benitah,S.A. and Di Croce,L. (2013)
RYBP and Cbx7 define specific biological functions of polycomb
complexes in mouse embryonic stem cells. Cell Rep., 3, 60–69.
48. Xia,Z., Anderson,M., Diaz,M.O. and Zeleznik-le,N.J. (2003) MLL
repression domain interacts with histone deacetylases, the polycomb
group proteins HPC2 and BMI-1, and the corepressor
C-terminal-binding protein. Proc. Natl. Acad. Sci. U.S.A., 100, 2–7.
49. Van Nuland,R., van Schaik,F.M., Simonis,M., van Heesch,S.,
Cuppen,E., Boelens,R., Timmers,H.M. and van Ingen,H. (2013)
Nucleosomal DNA binding drives the recognition of
H3K36-methylated nucleosomes by the PSIP1-PWWP domain.
Epigenet. Chromatin, 6, 12.
50. Horan,G.S., Wu,K., Wolgemuth,D.J. and Behringer,R.R. (1994)
Homeotic transformation of cervical vertebrae in Hoxa-4 mutant
mice. Proc. Natl. Acad. Sci. U.S.A., 91, 12644–12648.
51. Jeannotte,L., Lemieux,M., Charron,J., Poirier,F. and Robertson,E.J.
(1993) Specification of axial identity in the mouse: role of the Hoxa-5
(Hox1.3) gene. Genes Dev., 7, 2085–2096.
 at A
lbert Slom
an Library, U
niversity of Essex on O
ctober 16, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
9032 Nucleic Acids Research, 2014, Vol. 42, No. 14
52. Kostic,D. and Capecchi,M.R. (1994) Targeted disruptions of the
murine Hoxa4 and Hoxa6 genes result in homeotic transformations
of components of the vertebral column.Mech. Dev., 46, 231–247.
53. Cao,R., Tsukada,Y. and Zhang,Y. (2005) Role of Bmi-1 and Ring1A
in H2A ubiquitylation and Hox gene silencing.Mol. Cell, 20,
845–854.
54. Van der Lugt,N.M., Domen,J., Linders,K., van Roon,M.,
Robanus-Maandag,E., te Riele,H., van der Valk,M., Deschamps,J.,
Sofroniew,M. and van Lohuizen,M. (1994) Posterior transformation,
neurological abnormalities, and severe hematopoietic defects in mice
with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev., 8,
757–769.
55. Palijan,A., Fernandes,I., Verway,M., Kourelis,M., Bastien,Y.,
Tavera-Mendoza,L.E., Sacheli,A., Bourdeau,V., Mader,S. and
White,J.H. (2009) Ligand-dependent corepressor LCoR is an
attenuator of progesterone-regulated gene expression. J. Biol. Chem.,
284, 30275–30287.
56. Srinivasan,L. and Atchison,M.L. (2004) YY1 DNA binding and PcG
recruitment requires CtBP. Genes Dev., 18, 2596–2601.
57. Oswald,F., Winkler,M., Cao,Y., Astrahantseff,K., Bourteele,S.,
Knochel,W. and Borggrefe,T. (2005) RBP-J kappa / SHARP Recruits
CtIP / CtBP Corepressors To Silence Notch Target Genes.Mol. Cell
Biol. 25, 10379–10390.
58. Aymard,F., Bugler,B., Schmidt,C.K., Guillou,E., Caron,P., Briois,S.,
Iacovoni,J.S., Daburon,V., Miller,K.M., Jackson,S.P. et al. (2014)
Transcriptionally active chromatin recruits homologous
recombination at DNA double-strand breaks. Nat. Struct. Mol. Biol.,
21, 366–374.
59. Chinwalla,V., Jane,E.P. and Harte,P.J. (1995) The Drosophila
trithorax protein binds to specific chromosomal sites and is
co-localized with Polycomb at many sites. EMBO J., 14, 2056–2065.
60. Reynolds,N., O’Shaughnessy,A. and Hendrich,B. (2013)
Transcriptional repressors: multifaceted regulators of gene
expression. Development, 140, 505–512.
61. Ferrando,A.A., Armstrong,S.A., Neuberg,D.S., Sallan,S.E.,
Silverman,L.B., Korsmeyer,S.J. and Look,A.T. (2003) Gene
expression signatures in MLL-rearranged T-lineage and B-precursor
acute leukemias: dominance of HOX dysregulation. Blood, 102,
262–268.
62. Slany,R.K. (2009) The molecular biology of mixed lineage leukemia.
Haematologica, 94, 984–993.
63. Grand,F.H., Koduru,P., Cross,N.C.P. and Allen,S.L. (2005)
NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid
leukemia. Leuk. Res., 29, 1469–1472.
64. Hussey,D.J., Moore,S., Nicola,M. and Dobrovic,A. (2001) Fusion of
the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute
myeloid leukemia translocation. BMC Genet., 2, 20.
65. Yamamoto,K., Nakamachi,Y., Yakushijin,K., Funakoshi,Y.,
Okamura,A., Kawano,S., Matsuoka,H. and Minami,H. (2012)
Expression of the novel NUP98/PSIP1 fusion transcripts in
myelodysplastic syndrome with t(9;11)(p22;p15). Eur. J. Haematol.,
88, 244–248.
 at A
lbert Slom
an Library, U
niversity of Essex on O
ctober 16, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
